Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS

OBJECTIVETo evaluate the efficacy and safety of onabotulinumtoxinA 100 U in noncatheterizing patients with multiple sclerosis (MS) with urinary incontinence (UI) due to neurogenic detrusor overactivity (NDO). METHODSIn this randomized, double-blind phase III study, patients received onabotulinumtoxi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology 2018-08, Vol.91 (7), p.e657-e665
Hauptverfasser:	Tullman, Mark, Chartier-Kastler, Emmanuel, Kohan, Alfred, Keppenne, Veronique, Brucker, Benjamin M, Egerdie, Blair, Mandle, Meryl, Nicandro, Jean Paul, Jenkins, Brenda, Denys, Pierre
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Botulinum Toxins, Type A - therapeutic use Dose-Response Relationship, Drug Double-Blind Method Europe Female Follow-Up Studies Humans Male Middle Aged Multiple Sclerosis - complications Multiple Sclerosis - drug therapy Multiple Sclerosis - psychology Neurotoxins - therapeutic use North America Quality of Life - psychology Treatment Outcome Urodynamics - drug effects Urologic Diseases - drug therapy Urologic Diseases - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!